Updated diagnostic criteria expand anatomic locations, incorporate new biomarkers, and allow MS diagnosis without mandatory dissemination in time demonstration.
🔬 Clinical Considerations
- Optic nerve added as a 5th DIS location, requiring orbital MRI, OCT intereye difference ≥6 μm, or delayed VEP latencies to confirm involvement
- DIT is no longer mandatory; extent of spatial involvement plus CSF biomarkers or MRI markers can establish diagnosis in qualifying cases
- Kappa free light chain now interchangeable with oligoclonal bands for DIT substitution, offering faster, automated, rater-independent results with comparable accuracy
- CVS and paramagnetic rim lesions add specificity: Select-6 CVS achieves 90% sensitivity/89% specificity; ≥4 PRLs signal greater neurologic disability risk
- Patients aged ≥50 or with vascular comorbidities require additional confirmatory features (classical spinal cord lesion, positive CSF, or Select-6) to reduce misdiagnosis
🎯 Practice Applications
- Order orbital MRI and OCT when optic neuritis is suspected to satisfy the new optic nerve DIS criterion
- Request CSF KFLC testing as a practical alternative when OCB testing faces turnaround or access limitations
- Apply Select-6 CVS criteria on susceptibility-weighted sequences for patients with vascular risk factors or age ≥50
- Reassess existing CIS and RIS diagnoses against 2024 criteria: some patients may now qualify for formal MS diagnosis without new clinical events
More in MS
PATIENT EDUCATION
OBESITY/WEIGHT MANAGEMENT
EXERCISE/TRAINING
LEGAL MATTERS
GUIDELINES/RECOMMENDATIONS